Identifying responders to gabapentin for the treatment of alcohol use disorder: an exploratory machine learning approach.
Background Gabapentin, an anticonvulsant medication, has been proposed as a treatment for alcohol use disorder (AUD). A multisite study tested gabapentin enacarbil extended-release (GE-XR; 600 mg/twice a day), a prodrug formulation, combined with a computerized behavioral intervention, for AUD. In t...
| Publicado en: | Alcohol & Alcoholism Vol. 60; no. 3; pp. 1 - 11 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Oxford University Press / USA
May2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |